These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. ARID1A regulates DNA repair through chromatin organization and its deficiency triggers DNA damage-mediated anti-tumor immune response. Bakr A; Della Corte G; Veselinov O; Kelekçi S; Chen MM; Lin YY; Sigismondo G; Iacovone M; Cross A; Syed R; Jeong Y; Sollier E; Liu CS; Lutsik P; Krijgsveld J; Weichenhan D; Plass C; Popanda O; Schmezer P Nucleic Acids Res; 2024 Jun; 52(10):5698-5719. PubMed ID: 38587186 [TBL] [Abstract][Full Text] [Related]
6. Targeting ARID1A-mutant colorectal cancer: depletion of ARID1B increases radiosensitivity and modulates DNA damage response. Niedermaier B; Sak A; Zernickel E; Xu S; Groneberg M; Stuschke M Sci Rep; 2019 Dec; 9(1):18207. PubMed ID: 31796878 [TBL] [Abstract][Full Text] [Related]
7. Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy. Park Y; Chui MH; Suryo Rahmanto Y; Yu ZC; Shamanna RA; Bellani MA; Gaillard S; Ayhan A; Viswanathan A; Seidman MM; Franco S; Leung AKL; Bohr VA; Shih IM; Wang TL Clin Cancer Res; 2019 Sep; 25(18):5584-5594. PubMed ID: 31196855 [TBL] [Abstract][Full Text] [Related]
8. An insight into understanding the coupling between homologous recombination mediated DNA repair and chromatin remodeling mechanisms in plant genome: an update. Banerjee S; Roy S Cell Cycle; 2021 Sep; 20(18):1760-1784. PubMed ID: 34437813 [TBL] [Abstract][Full Text] [Related]
9. Targeting ARID1A mutations in cancer. Mullen J; Kato S; Sicklick JK; Kurzrock R Cancer Treat Rev; 2021 Nov; 100():102287. PubMed ID: 34619527 [TBL] [Abstract][Full Text] [Related]
10. The Chromatin Remodeling Component Arid1a Is a Suppressor of Spontaneous Mammary Tumors in Mice. Kartha N; Shen L; Maskin C; Wallace M; Schimenti JC Genetics; 2016 Aug; 203(4):1601-11. PubMed ID: 27280691 [TBL] [Abstract][Full Text] [Related]
11. SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability. Watanabe R; Ui A; Kanno S; Ogiwara H; Nagase T; Kohno T; Yasui A Cancer Res; 2014 May; 74(9):2465-75. PubMed ID: 24788099 [TBL] [Abstract][Full Text] [Related]
12. The transcriptional histone acetyltransferase cofactor TRRAP associates with the MRN repair complex and plays a role in DNA double-strand break repair. Robert F; Hardy S; Nagy Z; Baldeyron C; Murr R; Déry U; Masson JY; Papadopoulo D; Herceg Z; Tora L Mol Cell Biol; 2006 Jan; 26(2):402-12. PubMed ID: 16382133 [TBL] [Abstract][Full Text] [Related]
13. The Tumor Suppressor ARID1A Controls Global Transcription via Pausing of RNA Polymerase II. Trizzino M; Barbieri E; Petracovici A; Wu S; Welsh SA; Owens TA; Licciulli S; Zhang R; Gardini A Cell Rep; 2018 Jun; 23(13):3933-3945. PubMed ID: 29949775 [TBL] [Abstract][Full Text] [Related]
14. ARID1A-dependent maintenance of H3.3 is required for repressive CHD4-ZMYND8 chromatin interactions at super-enhancers. Reske JJ; Wilson MR; Armistead B; Harkins S; Perez C; Hrit J; Adams M; Rothbart SB; Missmer SA; Fazleabas AT; Chandler RL BMC Biol; 2022 Sep; 20(1):209. PubMed ID: 36153585 [TBL] [Abstract][Full Text] [Related]
15. ARID1A loss in cancer: Towards a mechanistic understanding. Mathur R Pharmacol Ther; 2018 Oct; 190():15-23. PubMed ID: 29730444 [TBL] [Abstract][Full Text] [Related]
16. The Role of the AT-Rich Interaction Domain 1A Gene ( Li JJ; Lee CS Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38275587 [TBL] [Abstract][Full Text] [Related]
17. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Guan B; Wang TL; Shih IeM Cancer Res; 2011 Nov; 71(21):6718-27. PubMed ID: 21900401 [TBL] [Abstract][Full Text] [Related]